Pixantrone for the treatment of adult patients with relapsed or refractory aggressive non-Hodgkin B-cell lymphomas

Treatment of patients with relapsed or refractory aggressive non-Hodgkin B-cell lymphoma remains an unmet clinical need, and the progressive myocardial toxicity related to cumulative, dose-dependent damage induced by anthracyclines represents a tricky issue in the planning of therapy. Pixantrone is...

Descripción completa

Detalles Bibliográficos
Autores principales: Volpetti, Stefano, Zaja, Francesco, Fanin, Renato
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4049882/
https://www.ncbi.nlm.nih.gov/pubmed/24926199
http://dx.doi.org/10.2147/OTT.S34055

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4049882/
https://www.ncbi.nlm.nih.gov/pubmed/24926199
http://dx.doi.org/10.2147/OTT.S34055

Ejemplares similares